Recommended
Recommended
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Akili Interactive

Shionogi Begins Phase 3 Study in Japan of Akili’s Digital Treatment in Children with ADHD
From Akili Interactive
Via Business Wire
Akili Announces Public Company Board of Director Nominees
From Akili Interactive
Via Business Wire
Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
From Akili Interactive
Via Business Wire
Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
From Akili Interactive
Via Business Wire
Tickers DNAA RBLX
The American Journal of Psychiatry Publishes Data Demonstrating Akili Interactive’s Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults with Major Depressive Disorder When Combined with Antidepressant Medication
From Akili Interactive
Via Business Wire
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit
From Akili Interactive
Via Business Wire
Tickers DNAA
Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer
From Akili Interactive
Via Business Wire
Tickers DNAA
Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022
From Akili Interactive
Via Business Wire
Tickers DNAA
Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
From Akili Interactive
Via Business Wire
Tickers DNAA
Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
From Akili Interactive
Via Business Wire
Tickers DNAA
Akili Founders Recognized by Newsweek on Inaugural List of America’s 50 Greatest Disruptors
From Akili Interactive
Via Business Wire
Topline Results from Shionogi Phase 2 Study in Japan Show Akili’s Digital Treatment Was Well-received and Improved Inattention Symptoms in Children with ADHD
From Akili Interactive
Via Business Wire
Akili Announces EndeavorRx® Is Now Available on Android™ Devices, Expanding Access for Children with ADHD
From Akili Interactive
Via Business Wire
Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
From Akili Interactive
Via Business Wire
Tickers ASX:TD1
Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children with ADHD
From Akili Interactive
Via Business Wire
Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
From Akili Interactive
Via Business Wire
Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for Patients with COVID Brain Fog
From Akili Interactive
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.